¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"maximum urea clearance"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • maximum compliance
    ÃÖ´ë¼øÀÀµµ
  • maximum dose
    1. ÃÖ´ë¿ë·® 2. ÃÖ´ë¼±·®
  • maximum expiratory flow rate
    ÃÖ°í³¯¼ûÀ¯¼Ó, ÃÖ°íÈ£±âÀ¯¼Ó
  • maximum flow rate
    1. ÃÖ°íÀ¯¼Ó 2. ÃÖ°íÈ帧¼Óµµ 3. ÃÖ´ëÀ¯·®
  • maximum gradient strength
    ÃÖ´ë±â¿ï±â¼¼±â, ÃÖ´ë°æ»ç°­µµ
  • maximum heart rate
    ÃÖ´ë½ÉÀå¹Úµ¿¼ö, ÃÖ´ë½É¹Ú¼ö
  • maximum intensity projection
    ÃÖ´ë°­µµÅõ»ç
  • maximum midexpiratory flow
    ÃÖ´ëÁß°£³¯¼ûÀ¯·®, ÃÖ´ëÁß°£È£±âÀ¯·®
  • maximum oxygen debt
    ÃÖ´ë»ê¼ÒºÎä
  • maximum permissible concentration
    ÃÖ´ëÇã¿ë³óµµ
  • maximum permissible level
    ÃÖ´ëÇã¿ë¼öÁØ
  • maximum permissible limit
    ÃÖ´ëÇã¿ëÇѰè
  • maximum phonation time
    ÃÖÀå¹ß¼ºÁö¼Ó½Ã°£
  • maximum power output
    ÃÖ´ëÃâ·Â
  • maximum safe intensity level
    ÃÖ´ë¾ÈÀü°­µµ¼öÁØ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • maximum acceptable daily intake
    ÀÏÀϼ·ÃëÃÖ´ëÇã¿ë·®
  • maximum allowable limit
    ÃÖ´ëÇã¿ëÇѰè
  • maximum permissible level
    ÃÖ´ëÇã¿ë¼öÁØ
  • maximum permissible limit
    ÃÖ´ëÇã¿ëÇѰè
  • maximum safe intensity level
    ÃÖ´ë¾ÈÀü°­µµ¼öÁØ
  • maximum
    ÃÖ´ë
  • maximum transport
    ÃÖ´ë¿î¹ÝÄ¡, ÃÖ´ëÀ̵¿Ä¡
  • maximum allowable value
    ÃÖ´ëÇã¿ëÄ¡
  • maximum articulation score
    ÃÖ°í¸í·áµµ
  • maximum cardiac output
    ÃÖ´ë½ÉÀå¹ÚÃâ·®
  • maximum discrimination score
    ÃÖ´ë¸í·áµµ
  • maximum expiratory flow rate
    Ãִ볯¼ûÀ¯·®·ü
  • maximum flow rate
    ÃÖ´ë¿ä¼Ó
  • maximum gradient strength
    ÃÖ´ë°æ»ç¼¼±â, ÃÖ´ë±â¿ï±â¼¼±â
  • maximum heart rate
    ÃÖ´ë½ÉÀå¹Úµ¿¼ö
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • clearance test
    û¼Ò½ÃÇè
  • clearance, immune
    ¸é¿ª¸Å°³Á¦°Å
  • creatinine clearance
    Å©·¹¾ÆÆ¼´ÑÁ¦°Å(¡­ð¶ËÛ).
  • creatinine clearance
    Å©·¹¾ÆÆ¼´Ñ Á¦°Å
  • creatinine clearance
    Å©·¹¾ÆÆ¼´Ñ û¼Ò(Ä¡,À²)
  • creatinine clearance test
    Å©·¹¾ÆÆ¼´ÑÁ¦°Å½ÃÇè(¡­ð¶ËÛãËúÐ).
  • dermal clearance
    ÁøÇÇ Ã»¼Ò(À²)
  • free water clearance
    À¯¸®¼öºÐû¼Ò(À²)
  • free water clearance
    À¯¸®¼öºÐû¼ÒÀ²(ë´×îâ©ÝÂôèá·ëÏ).
  • glomerular clearance
    »ç±¸Ã¼Ã»¼Ò¿ëÀû(¡­ôèá·é»îÝ).
  • hippurate clearance
    ¸¶´¢»êû¼Ò(À²)
  • immune clearance
    ¸é¿ªÅ¬¸®¾î·±½º.
  • immune clearance
    ¸é¿ªÅ¬¸®¾î·±½º.
  • intercompartmental clearance
    ºÐȹ°£ Á¦°ÅÀ².
  • inulin clearance
    ÀÌ´­¸°Å¬¸®¾î·±½º.
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 3
MPE malignant proliferation of eosinophils; maximum permissible exposure; maximum possible error; Medica...
MPI mannose phosphate isomerase; master patient index; maximum permitted intake; maximum point of impuls...
MTC mass transfer coefficient; maximum tolerated concentration; maximum toxic concentration; medical tes...
Tmax maximum threshold; time of maximum concentration
ANTU Alpha(¥á)-Naphthyl-Thio-Urea
  1) ÇÕ¼º »ì¼­Á¦
  2) ȸ»öºÐ¸»
  3) LD50;...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 3
UBT Urea Breath test
UKM Urea kinetic modeling
URR Urea Reduction Ratio
UKM Urea kinetic model
UN Urea nitrogen
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 3 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • maximum tolerance dose
    ÃÖ´ë ³»¿ë·®, ÃÖ´ë °ßµõ ¼±·®
  • maximum urethral closure pressure
    ÃÖ°í ¿äµµ Æó¼â¾Ð
  • maximum vapor tension
    ÃÖ´ë Áõ±â Àå·Â
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 7 ÆäÀÌÁö: 3
inulin clearance An accurate measure of the rate of filtration through the renal glomeruli, because inulin filters freely with water and is neither excreted nor reabsorbed through tubule walls. Inulin is not a normal constituent of plasma and must be infused continously to maintain a steady plasma concentration and a steady rate of urinary excretion during the measurement. Inulin clearance in a normal adult person is about 120 ml/min (range 100-150) per 1.73 m2 body surface area.
(05 Mar 2000)
isotope clearance The rate at which an isotope is removed (usually by blood flow) from a tissue or organ such as the brain.
(05 Mar 2000)
occlusal clearance A condition in which the opposing occlusal surfaces may glide over one another without any interfering projection.
(05 Mar 2000)
osmolal clearance The volume of urine that would be excreted per minute if the urinary solutes were accompanied by just enough water to make the urine isosmotic with plasma, i.e., so that the solute excretion did not change the osmolality of body fluids. To calculate it, the volume of urine excreted per minute is multiplied by the urinary osmolality (usually measured by freezing point depression) and divided by the plasma osmolality. Osmolal clearance is less than actual urine flow when urine is hyposmotic and exceeds it when urine is hyperosmotic.
(05 Mar 2000)
endogenous creatinine clearance A term distinguishing measurements based on the creatinine normally present in plasma; since no infusion is necessary, an average value may be obtained by collecting urine for a long period, e.g., 24 hours.
(05 Mar 2000)
exogenous creatinine clearance A term distinguishing measurements based on infusing creatinine intravenously to raise its plasma concentration and facilitate its accurate chemical determination.
(05 Mar 2000)
free water clearance The amount of water excreted in the urine beyond that which would accompany the excreted solutes if the urine were isosmotic with plasma; it represents the loss of body water in excess of solute tending to raise body osmolality and making urine hyposmotic. Unlike other clearance's, it is calculated by subtracting the osmolal clearance from the actual volume of urine excreted per minute. A negative value for free water clearance represents the amount of water that the body has reclaimed from isosmotic tubule fluid to make the urine hyperosmotic and to lower body osmolality.
(05 Mar 2000)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 3
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 3
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 3
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 3
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 3
ÅëÇÕ°Ë»ö ¿Ï·á